ANTX logo

AN2 Therapeutics, Inc. Common Stock


ANTX: AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.


Show ANTX Financials

Consumer Interest
SEC Filings

Recent trades of ANTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ANTX's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases


Number of mentions of ANTX in WallStreetBets Daily Discussion


Recent insights relating to ANTX

CNBC Recommendations

Recent picks made for ANTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ANTX

Corporate Flights

Flights by private jets registered to ANTX